Overview

Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole

Status:
RECRUITING

Trial end date:
2025-11-30

Target enrollment:

Participant gender:

Summary

The objective of this clinical trial is to compare which of the two drugs best resolves symptoms in patients diagnosed with erosive and non-erosive gastroesophageal reflux disease, adult males and females. The main question is What is the proportion of patients with resolution of the main symptoms of gastroesophageal reflux disease at four weeks of treatment with pantoprazole vs tegoprazan.

Phase:

PHASE4

Details

Lead Sponsor:

Carnot Laboratories

Treatments:

Pantoprazole
tegoprazan